These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23142852)

  • 1. Variations in Physician Attitudes Regarding ADHD and Their Association With Prescribing Practices.
    Sheldrick RC; Leslie LK; Rodday AM; Parsons SK; Saunders TS; Wong JB
    J Atten Disord; 2015 Jul; 19(7):569-77. PubMed ID: 23142852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician perceptions of the use of medications for attention deficit hyperactivity disorder.
    Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR
    J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices to prevent ADHD stimulant diversion and misuse.
    Colaneri N; Keim S; Adesman A
    J Subst Abuse Treat; 2017 Mar; 74():26-34. PubMed ID: 28132697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
    Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
    Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of inter-practice variation in ADHD diagnosis and stimulant prescribing: cross-sectional database study of a national surveillance network.
    Hoang U; James AC; Liyanage H; Jones S; Joy M; Blair M; Rigby M; Lusignan S
    BMJ Evid Based Med; 2019 Aug; 24(4):155-161. PubMed ID: 30765384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, Attitudes, and Practice Patterns of Health Professionals Toward Medical and Non-medical Stimulant Use by Young Adults.
    Loskutova NY; Waterman J; Callen E; Staton EW; Bullard E; Shields J
    J Am Board Fam Med; 2020; 33(1):59-70. PubMed ID: 31907247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social adversity and regional differences in prescribing of ADHD medication for school-age children.
    Wallach-Kildemoes H; Skovgaard AM; Thielen K; Pottegård A; Mortensen LH
    J Dev Behav Pediatr; 2015 Jun; 36(5):330-41. PubMed ID: 25997081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant prescriptions by psychiatrists higher than expected: a self-report survey.
    Beck C; Silverstone P; Glor K; Dunn J
    Can J Psychiatry; 1999 Sep; 44(7):680-4. PubMed ID: 10500869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands.
    Faber A; Kalverdijk LJ; de Jong-van den Berg LT; Hugtenburg JG; Minderaa RB; Tobi H
    Eur Child Adolesc Psychiatry; 2010 Feb; 19(2):159-66. PubMed ID: 19894075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
    Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
    Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What stops practitioners discussing medication breaks in children and adolescents with ADHD? Identifying barriers through theory-driven qualitative research.
    Ibrahim K; Donyai P
    Atten Defic Hyperact Disord; 2018 Dec; 10(4):273-283. PubMed ID: 29982921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Age Children: Child and Adolescent Psychiatrists' Adherence to Clinical Practice Guidelines.
    Chung J; Tchaconas A; Meryash D; Adesman A
    J Child Adolesc Psychopharmacol; 2016 May; 26(4):335-43. PubMed ID: 27105063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY; Yeh HH; Fang SY; Wu EC; Chang IS; Lin KM
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Training and Qualification to Educate Patients on Attention-Deficit/Hyperactivity Disorder Stimulant Diversion and Misuse.
    Colaneri N; Keim SA; Adesman A
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):554-561. PubMed ID: 30124331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed.
    Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD
    Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
    Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
    Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ).
    Kovshoff H; Vrijens M; Thompson M; Yardley L; Hodgkins P; Sonuga-Barke EJ; Danckaerts M
    Eur Child Adolesc Psychiatry; 2013 Sep; 22(9):533-42. PubMed ID: 23455602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
    Albert M; Rui P; Ashman JJ
    NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.